{"entity":{"type":"insider","cik":"0001620743","url":"/insider/0001620743","json_url":"/insider/0001620743.json","name":"KEATING LAURIE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":19,"first":"2017-05-31","last":"2023-01-19","span_basis":"filed_date"},"name_variants":[{"name":"KEATING LAURIE","source":"filing","n_filings":19,"first_seen":"2017-05-31","last_seen":"2023-01-19"}],"transactions":[{"id":6244432,"accession":"0001415889-22-005150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-005150","line_url":"/filing/0001415889-22-005150#line-1","is_derivative":false,"issuer_cik":"0001620743","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001620743","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Director","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":8257360,"accession":"0001127602-23-001831","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-001831","line_url":"/filing/0001127602-23-001831#line-1","is_derivative":false,"issuer_cik":"0001620743","issuer_name":"PepGen Inc.","issuer_ticker":"PEPG","issuer_name_source":null,"issuer_url":"/issuer/0001620743","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4166.0,"shares_display":"4,166","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":49992.0,"total_display":"49,992.00","shares_owned_after":4166.0,"shares_owned_after_display":"4,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-06","filed_date":"2023-01-19","scope":"insider"},{"id":5232281,"accession":"0001735276-21-000079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-21-000079","line_url":"/filing/0001735276-21-000079#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":188.95,"price_display":"188.95","price_state":"stated","total_value":1889500.0,"total_display":"1,889,500.00","shares_owned_after":5132.0,"shares_owned_after_display":"5,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-09","scope":"insider"},{"id":4987695,"accession":"0001104659-21-099736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-099736","line_url":"/filing/0001104659-21-099736#line-1","is_derivative":false,"issuer_cik":"0001620743","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001620743","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Director","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":105000.0,"total_display":"105,000.00","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-04","scope":"insider"},{"id":4836058,"accession":"0001735276-21-000053","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-21-000053","line_url":"/filing/0001735276-21-000053#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":178.95,"price_display":"178.95","price_state":"stated","total_value":894750.0,"total_display":"894,750.00","shares_owned_after":5132.0,"shares_owned_after_display":"5,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-14","scope":"insider"},{"id":4836054,"accession":"0001735276-21-000053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-21-000053","line_url":"/filing/0001735276-21-000053#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1812.0,"shares_display":"1,812","price_per_share":179.0,"price_display":"179.00","price_state":"stated","total_value":324348.0,"total_display":"324,348.00","shares_owned_after":10132.0,"shares_owned_after_display":"10,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-14","scope":"insider"},{"id":5534428,"accession":"0001735276-21-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001735276-21-000047","line_url":"/filing/0001735276-21-000047#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1734.0,"shares_display":"1,734","price_per_share":154.0,"price_display":"154.00","price_state":"stated","total_value":267036.0,"total_display":"267,036.00","shares_owned_after":5132.0,"shares_owned_after_display":"5,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":5014191,"accession":"0001735276-21-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-21-000006","line_url":"/filing/0001735276-21-000006#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":169.0,"price_display":"169.00","price_state":"stated","total_value":845000.0,"total_display":"845,000.00","shares_owned_after":6261.0,"shares_owned_after_display":"6,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-15","scope":"insider"},{"id":5014187,"accession":"0001735276-21-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-21-000006","line_url":"/filing/0001735276-21-000006#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":170.0,"price_display":"170.00","price_state":"stated","total_value":510000.0,"total_display":"510,000.00","shares_owned_after":3261.0,"shares_owned_after_display":"3,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-15","scope":"insider"},{"id":5014181,"accession":"0001735276-21-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-21-000006","line_url":"/filing/0001735276-21-000006#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1027.0,"shares_display":"1,027","price_per_share":174.0,"price_display":"174.00","price_state":"stated","total_value":178698.0,"total_display":"178,698.00","shares_owned_after":2234.0,"shares_owned_after_display":"2,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-15","scope":"insider"},{"id":4400054,"accession":"0001735276-21-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-21-000004","line_url":"/filing/0001735276-21-000004#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11941.0,"shares_display":"11,941","price_per_share":159.0,"price_display":"159.00","price_state":"stated","total_value":1898619.0,"total_display":"1,898,619.00","shares_owned_after":5234.0,"shares_owned_after_display":"5,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-13","scope":"insider"},{"id":4400050,"accession":"0001735276-21-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-21-000004","line_url":"/filing/0001735276-21-000004#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":165.0,"price_display":"165.00","price_state":"stated","total_value":495000.0,"total_display":"495,000.00","shares_owned_after":2234.0,"shares_owned_after_display":"2,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-13","scope":"insider"},{"id":4400037,"accession":"0001735276-21-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001735276-21-000004","line_url":"/filing/0001735276-21-000004#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":758.0,"shares_display":"758","price_per_share":154.0,"price_display":"154.00","price_state":"stated","total_value":116732.0,"total_display":"116,732.00","shares_owned_after":2234.0,"shares_owned_after_display":"2,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":2656155,"accession":"0001735276-20-000090","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-20-000090","line_url":"/filing/0001735276-20-000090#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15618.0,"shares_display":"15,618","price_per_share":161.32,"price_display":"161.32","price_state":"stated","total_value":2519495.76,"total_display":"2,519,495.76","shares_owned_after":12522.0,"shares_owned_after_display":"12,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":2656150,"accession":"0001735276-20-000090","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-20-000090","line_url":"/filing/0001735276-20-000090#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14236.0,"shares_display":"14,236","price_per_share":160.52,"price_display":"160.52","price_state":"stated","total_value":2285162.72,"total_display":"2,285,162.72","shares_owned_after":28140.0,"shares_owned_after_display":"28,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":2656146,"accession":"0001735276-20-000090","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-20-000090","line_url":"/filing/0001735276-20-000090#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9530.0,"shares_display":"9,530","price_per_share":162.24,"price_display":"162.24","price_state":"stated","total_value":1546147.2,"total_display":"1,546,147.20","shares_owned_after":2992.0,"shares_owned_after_display":"2,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":2656143,"accession":"0001735276-20-000090","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-20-000090","line_url":"/filing/0001735276-20-000090#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4482.0,"shares_display":"4,482","price_per_share":157.16,"price_display":"157.16","price_state":"stated","total_value":704391.12,"total_display":"704,391.12","shares_owned_after":45760.0,"shares_owned_after_display":"45,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":2656139,"accession":"0001735276-20-000090","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-20-000090","line_url":"/filing/0001735276-20-000090#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2323.0,"shares_display":"2,323","price_per_share":158.27,"price_display":"158.27","price_state":"stated","total_value":367661.21,"total_display":"367,661.21","shares_owned_after":43437.0,"shares_owned_after_display":"43,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":2656135,"accession":"0001735276-20-000090","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-20-000090","line_url":"/filing/0001735276-20-000090#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1061.0,"shares_display":"1,061","price_per_share":159.22,"price_display":"159.22","price_state":"stated","total_value":168932.42,"total_display":"168,932.42","shares_owned_after":42376.0,"shares_owned_after_display":"42,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":2768118,"accession":"0001735276-20-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-20-000056","line_url":"/filing/0001735276-20-000056#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":139.0,"price_display":"139.00","price_state":"stated","total_value":1390000.0,"total_display":"1,390,000.00","shares_owned_after":14492.0,"shares_owned_after_display":"14,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-20","filed_date":"2020-04-22","scope":"insider"},{"id":2876813,"accession":"0001735276-20-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-20-000014","line_url":"/filing/0001735276-20-000014#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":129.0,"price_display":"129.00","price_state":"stated","total_value":1290000.0,"total_display":"1,290,000.00","shares_owned_after":12258.0,"shares_owned_after_display":"12,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"},{"id":3268355,"accession":"0001735276-20-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-20-000004","line_url":"/filing/0001735276-20-000004#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6337.0,"shares_display":"6,337","price_per_share":119.0,"price_display":"119.00","price_state":"stated","total_value":754103.0,"total_display":"754,103.00","shares_owned_after":8595.0,"shares_owned_after_display":"8,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-29","filed_date":"2020-01-31","scope":"insider"},{"id":2044393,"accession":"0001735276-20-000002","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-20-000002","line_url":"/filing/0001735276-20-000002#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13631.0,"shares_display":"13,631","price_per_share":116.43,"price_display":"116.43","price_state":"stated","total_value":1587057.33,"total_display":"1,587,057.33","shares_owned_after":32636.0,"shares_owned_after_display":"32,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-29","scope":"insider"},{"id":2044392,"accession":"0001735276-20-000002","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-20-000002","line_url":"/filing/0001735276-20-000002#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13084.0,"shares_display":"13,084","price_per_share":118.61,"price_display":"118.61","price_state":"stated","total_value":1551893.24,"total_display":"1,551,893.24","shares_owned_after":15452.0,"shares_owned_after_display":"15,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-29","scope":"insider"},{"id":2044391,"accession":"0001735276-20-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-20-000002","line_url":"/filing/0001735276-20-000002#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":119.53,"price_display":"119.53","price_state":"stated","total_value":796906.51,"total_display":"796,906.51","shares_owned_after":8785.0,"shares_owned_after_display":"8,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-29","scope":"insider"},{"id":2044389,"accession":"0001735276-20-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-20-000002","line_url":"/filing/0001735276-20-000002#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":117.67,"price_display":"117.67","price_state":"stated","total_value":482447.0,"total_display":"482,447.00","shares_owned_after":28536.0,"shares_owned_after_display":"28,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-29","scope":"insider"},{"id":2044388,"accession":"0001735276-20-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-20-000002","line_url":"/filing/0001735276-20-000002#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3365.0,"shares_display":"3,365","price_per_share":115.55,"price_display":"115.55","price_state":"stated","total_value":388825.75,"total_display":"388,825.75","shares_owned_after":46267.0,"shares_owned_after_display":"46,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-29","scope":"insider"},{"id":2044373,"accession":"0001735276-20-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-20-000002","line_url":"/filing/0001735276-20-000002#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (EVP, Chief Legal Officer)","officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190.0,"shares_display":"190","price_per_share":120.21,"price_display":"120.21","price_state":"stated","total_value":22839.9,"total_display":"22,839.90","shares_owned_after":8595.0,"shares_owned_after_display":"8,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-29","scope":"insider"},{"id":6248129,"accession":"0001735276-18-000035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-18-000035","line_url":"/filing/0001735276-18-000035#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1563.0,"shares_display":"1,563","price_per_share":105.04,"price_display":"105.04","price_state":"stated","total_value":164177.52,"total_display":"164,177.52","shares_owned_after":14500.0,"shares_owned_after_display":"14,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-20","filed_date":"2018-06-22","scope":"insider"},{"id":6755223,"accession":"0001553878-18-000029","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001553878-18-000029","line_url":"/filing/0001553878-18-000029#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":149.97,"price_display":"149.97","price_state":"stated","total_value":74985.0,"total_display":"74,985.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-20","filed_date":"2018-03-22","scope":"insider"},{"id":6755220,"accession":"0001553878-18-000029","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001553878-18-000029","line_url":"/filing/0001553878-18-000029#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":462.0,"shares_display":"462","price_per_share":147.79,"price_display":"147.79","price_state":"stated","total_value":68278.98,"total_display":"68,278.98","shares_owned_after":15500.0,"shares_owned_after_display":"15,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-20","filed_date":"2018-03-22","scope":"insider"},{"id":6755214,"accession":"0001553878-18-000029","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-18-000029","line_url":"/filing/0001553878-18-000029#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":152.79,"price_display":"152.79","price_state":"stated","total_value":45837.0,"total_display":"45,837.00","shares_owned_after":14500.0,"shares_owned_after_display":"14,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-20","filed_date":"2018-03-22","scope":"insider"},{"id":6755211,"accession":"0001553878-18-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001553878-18-000029","line_url":"/filing/0001553878-18-000029#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":151.48,"price_display":"151.48","price_state":"stated","total_value":30296.0,"total_display":"30,296.00","shares_owned_after":14800.0,"shares_owned_after_display":"14,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-20","filed_date":"2018-03-22","scope":"insider"},{"id":6755208,"accession":"0001553878-18-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-18-000029","line_url":"/filing/0001553878-18-000029#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":146.36,"price_display":"146.36","price_state":"stated","total_value":14636.0,"total_display":"14,636.00","shares_owned_after":15962.0,"shares_owned_after_display":"15,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-20","filed_date":"2018-03-22","scope":"insider"},{"id":6353838,"accession":"0001553878-18-000023","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-18-000023","line_url":"/filing/0001553878-18-000023#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":150.0,"price_display":"150.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","shares_owned_after":14500.0,"shares_owned_after_display":"14,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-14","scope":"insider"},{"id":6353832,"accession":"0001553878-18-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-18-000023","line_url":"/filing/0001553878-18-000023#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":1400000.0,"total_display":"1,400,000.00","shares_owned_after":14500.0,"shares_owned_after_display":"14,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"},{"id":4920599,"accession":"0001325812-17-000038","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001325812-17-000038","line_url":"/filing/0001325812-17-000038#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4049.0,"shares_display":"4,049","price_per_share":120.8833,"price_display":"120.88","price_state":"stated","total_value":489456.4817,"total_display":"489,456.48","shares_owned_after":13700.0,"shares_owned_after_display":"13,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2017-12-21","scope":"insider"},{"id":4920596,"accession":"0001325812-17-000038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001325812-17-000038","line_url":"/filing/0001325812-17-000038#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":121.6747,"price_display":"121.67","price_state":"stated","total_value":231181.93,"total_display":"231,181.93","shares_owned_after":11800.0,"shares_owned_after_display":"11,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2017-12-21","scope":"insider"},{"id":4920592,"accession":"0001325812-17-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001325812-17-000038","line_url":"/filing/0001325812-17-000038#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALKS","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC & Secretary)","officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":122.5333,"price_display":"122.53","price_state":"stated","total_value":36759.99,"total_display":"36,759.99","shares_owned_after":11500.0,"shares_owned_after_display":"11,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2017-12-21","scope":"insider"},{"id":4360661,"accession":"0001553878-17-000070","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001553878-17-000070","line_url":"/filing/0001553878-17-000070#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC and Secretary)","officer_title":"SVP, GC and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":136.5,"price_display":"136.50","price_state":"stated","total_value":1324050.0,"total_display":"1,324,050.00","shares_owned_after":17699.0,"shares_owned_after_display":"17,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4360658,"accession":"0001553878-17-000070","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001553878-17-000070","line_url":"/filing/0001553878-17-000070#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC and Secretary)","officer_title":"SVP, GC and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":135.56,"price_display":"135.56","price_state":"stated","total_value":1016700.0,"total_display":"1,016,700.00","shares_owned_after":27399.0,"shares_owned_after_display":"27,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4360655,"accession":"0001553878-17-000070","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-17-000070","line_url":"/filing/0001553878-17-000070#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC and Secretary)","officer_title":"SVP, GC and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6199.0,"shares_display":"6,199","price_per_share":137.29,"price_display":"137.29","price_state":"stated","total_value":851060.71,"total_display":"851,060.71","shares_owned_after":11500.0,"shares_owned_after_display":"11,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4360654,"accession":"0001553878-17-000070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001553878-17-000070","line_url":"/filing/0001553878-17-000070#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC and Secretary)","officer_title":"SVP, GC and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3801.0,"shares_display":"3,801","price_per_share":134.59,"price_display":"134.59","price_state":"stated","total_value":511576.59,"total_display":"511,576.59","shares_owned_after":34899.0,"shares_owned_after_display":"34,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4360649,"accession":"0001553878-17-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553878-17-000070","line_url":"/filing/0001553878-17-000070#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC and Secretary)","officer_title":"SVP, GC and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":133.37,"price_display":"133.37","price_state":"stated","total_value":373436.0,"total_display":"373,436.00","shares_owned_after":38700.0,"shares_owned_after_display":"38,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":5299203,"accession":"0001553878-17-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001553878-17-000015","line_url":"/filing/0001553878-17-000015#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001620743","owner_name":"KEATING LAURIE","owner_url":"/insider/0001620743","role":"Officer (SVP, GC and Secretary)","officer_title":"SVP, GC and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11500.0,"shares_display":"11,500","price_per_share":65.348,"price_display":"65.35","price_state":"stated","total_value":751502.0,"total_display":"751,502.00","shares_owned_after":11500.0,"shares_owned_after_display":"11,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-30","filed_date":"2017-05-31","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001835597","name":"PepGen Inc.","url":"/issuer/0001835597","role":"Director","n_filings":1,"first_seen":"2023-01-19","last_seen":"2023-01-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001790340","name":"Immuneering Corp","url":"/issuer/0001790340","role":"Director","n_filings":2,"first_seen":"2021-08-04","last_seen":"2022-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (EVP, Chief Legal Officer)","n_filings":16,"first_seen":"2017-05-31","last_seen":"2021-08-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001620743","retrieved_at":"2026-08-21T12:25:35+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}